Spero Therapeutics Inc Capital Reinvestment Ratio

Latest as of December 2022: 0.00x

Spero Therapeutics Inc capital reinvestment ratio. Spero Therapeutics Inc (SPRO) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($44.48 Million) in capital expenditures ($129.00K). Check cash flow reinvestment rate of Spero Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$44.48 Million

USD

Capital Expenditures

$129.00K

USD

Data as of

Dec 2022

Most recent filing

Spero Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Spero Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Spero Therapeutics Inc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow